Non-falciparum species and submicroscopic infections in three epidemiological malaria facets in Cameroon

BMC Infectious Diseases

Table 3 Characteristics of P. vivax and P. ovale infections

Malaria species	Parasitemia (parasites/µL)	Malaria and parasitemia	G6PD status	Hospital treatment prescribed	Patient outcome
P. ovale curtisi^a§	4870	Symptomatic and microscopic	G6PD-n	AS + AQ	Discharged
P. ovale curtisi^b**	850	Symptomatic and microscopic	G6PD-n	AS + AQ	Discharged
P. ovale curtisi^c**	1453	Symptomatic and microscopic	G6PD-n	AL	Discharged
P. vivax^§	1500	Symptomatic and microscopic	G6PD-n	NA	NA

AS + AQ Artesunate + Amodiaquine, AL Artemether + Lumefantrine, G6PD Glucose-6-Phosphate Dehydrogenase, G6PD-n Glucose-6-Phosphate Dehydrogenase—No deficiency, NA not available;
P. ovale curtisi (samples a, b and c identified in the study)
^**Mono-infection
^§Co-infection with P. falciparum

ISSN: 1471-2334